Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions Volume 38

ISBN-13: 9780444637185 / Angielski / Twarda / 2016 / 604 str.

Sidhartha D. Ray

Opis

Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions was first published in 1977, and has been continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each annual provides clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing their expertise each year.

• Provides a critical yearly survey of the new data and trends regarding the side effects of drugs
• Authored and reviewed by worldwide pioneers in the clinical and practice sciences
• Presents an essential clinical on the side effects of drugs for practitioners and healthcare professionals alike

Spis treści

Contributors

Preface

Special Reviews in SEDA 38

Table of Essays, Annuals 1-37

Abbreviations

ADRs, ADEs and SEDs: A Bird's Eye View

Chapter 1: Central Nervous System Stimulants and Drugs That Suppress Appetite

Chapter 2: Antidepressant Drugs

Chapter 3: Lithium

Chapter 4: Hypnotics and Sedatives

Chapter 5: Antipsychotic Drugs

Chapter 6: Antiepileptics

Chapter 7: Opioid Analgesics and Narcotic Antagonists

Chapter 8: Anti-Inflammatory and Antipyretic Analgesics and Drugs Used in Gout

Chapter 9: General Anaesthetics and Therapeutic Gases

Chapter 10: Local Anesthetics

Chapter 11: Neuromuscular Blocking Agents and Skeletal Muscle Relaxants

Chapter 12: Drugs That Affect Autonomic Functions or the Extrapyramidal System

Chapter 13: Dermatological Drugs, Topical Agents, and Cosmetics

Chapter 14: Antihistamines (H1 Receptor Antagonists)

Chapter 15: Drugs That Act on the Respiratory Tract

Chapter 16: Positive Inotropic Drugs and Drugs Used in Dysrhythmias

Chapter 17: Beta-Adrenoceptor Antagonists and Antianginal Drugs

Chapter 18: Antihypertensives

Chapter 19: Diuretics

Chapter 20: Metals

Chapter 21: Metal Antagonists

Chapter 22: Antiseptic Drugs and Disinfectants

Chapter 23: Beta-Lactams and Tetracyclines

Chapter 24: Miscellaneous Antibacterial Drugs

Chapter 25: Antifungal Drugs

Chapter 26: Antiprotozoal Drugs

Chapter 27: Antiviral Drugs

Chapter 28: Drugs Used in Tuberculosis and Leprosy

Chapter 29: Antihelminthic Drugs

Chapter 30: Vaccines

Chapter 31: Blood, Blood Components, Plasma, and Plasma Products

Chapter 32: Vitamins, Amino Acids, and Drugs and Formulations Used in Nutrition

Chapter 33: Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis

Chapter 34: Gastrointestinal Drugs

Chapter 35: Drugs That Act on the Immune System: Cytokines and Monoclonal Antibodies

Chapter 36: Drugs That Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs

Chapter 37: Corticotrophins, Corticosteroids, and Prostaglandins

Chapter 38: Sex Hormones and Related Compounds, Including Hormonal Contraceptives

Chapter 39: Thyroid hormones, Iodine and Iodides, and Antithyroid Drugs

Chapter 40: Insulin Other Hypoglycemic Drugs

Chapter 41: Miscellaneous Hormones

Chapter 42: Drugs That Affect Lipid Metabolism

Chapter 43: Cytostatic Agents-Tyrosine Kinase Inhibitors Utilized in the Treatment of Solid Malignancies

Chapter 44: Radiological Contrast Agents and Radiopharmaceuticals

Chapter 45: Drugs Used in Ocular Treatment

Chapter 46: Safety of Complementary and Alternative Medicine (CAM) Treatments and Practices

Chapter 47: Miscellaneous Drugs, Materials, Medical Devices and Techniques

Reviewers List

Index of Drugs

Index of Drug-Drug Interactions

Index of Adverse Effects and Adverse Reactions

O autorze

Sidhartha D. Ray, PhD, FACN serves as a Senior Professor of Pharmaceutical and Biomedical Sciences at The Touro College of Pharmacy at Manhattan, New York. Prior to this he served as Professor of Pharmaceutical Sciences for nearly 2 decades at the Arnold & Marie Schwartz College of Pharmacy and Health Sciences of Long Island University, New York, and as the founding chair of Pharmaceutical Science department at Manchester University College of Pharmacy, Indiana, USA. He has been in the health sciences academy for over 35 years mainly focusing on pharmacy teaching, research and service. Dr. Ray's research program focus on drug & chemical induced organ toxicology, mechanistic & molecular toxicology, adverse drug reaction mechanisms, side effects of a number of therapeutically relevant drugs and environmentally significant chemicals. Over the last two decades, Dr. Ray's seminal discoveries have provided clear understandings on the dynamic role of apoptosis, necrosis and necraptosis during organotoxic reactions and have influenced the development of safety measures for a stunning variety of xenobiotics, phytochemicals and nutraceuticals. He is internationally recognized as a leader in the scientific community and was one of the front runners in exploring mechanisms of drug and chemical-induced programmed and un-programmed cell death in in-vivo models. His landmark studies on the interplay of bcl-2, bcl-xl, p53, bad and bax during acetaminophen induced cell death and its prevention by grape seed proanthocyanidin extract has earned worldwide citations. His peer recognition and acknowledged service contributions are reflected by his election into multiple international professional organizations, such as the Society of Toxicology (SOT), Society of Free Radical Biology & Medicine (SFRBM), American Society of Pharmacology & Experimental Therapeutics (ASPET), American Association of Colleges of Pharmacy (AACP) and American College of Nutrition (ACN). Dr. Ray is an Associate Editor of Encyclopedia of Toxicology (3rd Ed, Elsevier, 2014), and serves on the editorial boards of multiple prestigious international journals, including 'Archives of Toxicology' and 'Oxidative Medicine & Cellular Longevity'.
Based on his contributions to teaching, service and scholarship to health sciences in general, Dr. Ray received multiple prestigious awards, inc. the American Academy of Clinical Toxicology's national research award (1996), 'Fellow of the American College of Nutrition' honor in 1999, David Newton Award for Excellence in Teaching Pharmacy (2005), the Biennial Abraham Krasnoff Memorial Award for Lifetime Scholarly Achievement (2008), Arnold & Marie Schwartz College of Pharmacy & Health Science's 'Wall-of-Fame' honor (2011), the Society of Toxicology's 'Undergraduate Educator of the Year' national award (2013), and the Manchester University's 'Outstanding Scholar of the Year' award (2014). He currently serves on the SOT-NIH-NLM's joint Toxlearn Project, SOT Undergraduate Task Force (2007 - present), and has previously served on the SOT's Education Committee (2007 - 2010). In his lifetime, Dr. Ray has mentored research to numerous PharmD, MS, MD and PhD students in a number of areas of toxicology and biomedical sciences, made seminal contributions to the fields of pharmacology, toxicology, free radical biology, anticancer mechanism, phytochemicals, nutraceuticals & dietary supplements, and molecular safety sciences. Dr. Ray loves to promote 'Lifelong Learning' strategies to his students and clearly models his beliefs day in and day out. Visit URL: www.sidhartharay.com/ for more details.